Nervous System Tumor Thyroid Cancer New Indication: Dabrafenib and Trametinib in bRAV V600E Mutant Anaplastic Thyroid Cancer Ulas D. Bayraktar, MD 2022-09-20
Nervous System Tumor New Indication: Dabrafenib and Trametinib in bRAF V600E Mutant Glioma Ulas D. Bayraktar, MD 2022-03-16
